Int. J. Mol. Sci. 2010, 11(7), 2699-2700; doi:10.3390/ijms11072699
Addendum

Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575

Hideya Ando 1,2,* email, Mary S. Matsui 3 email and Masamitsu Ichihashi 1,2 email
1 Skin Aging and Photo-aging Research Center, Doshisha University, Kizugawa, Kyoto 619-0225, Japan 2 Kobe Skin Research Institute, Kobe, Hyogo 650-0047, Japan 3 Biological Research Division, The Estee Lauder Companies Inc., Melville, New York 11747, NY, USA
* Author to whom correspondence should be addressed.
Received: 5 July 2010 / Accepted: 8 July 2010 / Published: 12 July 2010
(This article belongs to the Special Issue Inhibitors of Melanogenesis Related Processes: Application to Food and Cosmetic Industry)
PDF Full-text Download PDF Full-Text [23 KB, uploaded 12 July 2010 11:38 CEST]
Abstract: One additional skin lightening or whitening quasi-drug (QD) has been developed and officially approved by the Ministry of Health, Labor and Welfare of Japan.

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Ando, H.; Matsui, M.S.; Ichihashi, M. Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575. Int. J. Mol. Sci. 2010, 11, 2699-2700.

AMA Style

Ando H, Matsui MS, Ichihashi M. Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575. International Journal of Molecular Sciences. 2010; 11(7):2699-2700.

Chicago/Turabian Style

Ando, Hideya; Matsui, Mary S.; Ichihashi, Masamitsu. 2010. "Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575." Int. J. Mol. Sci. 11, no. 7: 2699-2700.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert